When someone is affected by aHUS, the issue of it being a rare disease soon becomes apparent. The injustices felt by those with rare diseases permeate the thinking of those…
What’s new in 2022 regarding expansion in atypical HUS knowledge, and advancements for investigational drugs which may have potential as new aHUS therapeutic treatments? As with most matters, COVID-19 priorities…
Atypical HUS patients and family caregivers are direct consumers of medical information and research, as we have a vested interest in learning about a medical condition that affects us personally.…
We’re very pleased to offer this second in our series of ‘aHUS around the World’ where we feature the news and views of patients in a specific nation. Thanks to…
Atypical HUS patients, family caregivers, and aHUS advocates are invited to attend a full day virtual meeting which will be held on Saturday, August 20th, 9:00am to 4:30pm EDT. It…
Six years ago, aHUS featured, along with another renal disease MPGN/C3G, in a controversies conference held by KDIGO (Kidney Disease Improving Global Outcomes, https://kdigo.org/ ) in Barcelona , Spain. Complement…
We’re pleased to feature this interview with Dr Brad Lewis, Medical Director of Machaon Diagnostics. A hematologist with background in biochemistry and focus on thrombosis and hemostasis, Dr Lewis lectures…
11am 23 June 2022, Bergamo,Italy: The long awaited ISN Frontiers meeting about Renal Complement diseases featuring aHUS is about to begin. Originally intended to be held in 2020 but postponed…